Evaluating cell-free DNA-based blood tests for early detection of multiple cancers

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

Researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining the clinical limit of detection (LOD) based on circulating tumor allele fraction (cTAF) enables the comparison of different approaches.

The Native Antigen Company introduces new range of influenza antigens

Previous article

The newest AirPods Pro just hit their lowest price ever — plus more of the best deals to shop today

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News